Yeo, Winnie
6 papers on CoChatORCID 0000-0002-0863-8469
Most cited papers
- Verified
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 4,280
- Verified
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Swain, S. M., Miles, D., Kim, S.-B., Im, Y.-H., Im, S.-A., Semiglazov, V., Ciruelos, E., Schneeweiss, A., Loi, S., Monturus, E., et al. (2020) · The Lancet Oncology
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 922
- Verified
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Rha, S. Y., Oh, D.-Y., Yañez, P., Bai, Y., Ryu, M.-H., Lee, J., Rivera, F., Alves, G. V., Garrido, M., Shiu, K.-K., et al. (2023) · The Lancet Oncology
Gastric Cancer Management and OutcomesCancer Immunotherapy and Biomarkers
Cited by 690
- Verified
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response
Yeo, W., Chan, S. L., Mo, F. K., Chu, C. M., Hui, J. W., Tong, J. H., Chan, A. W., Koh, J., Hui, E. P., Loong, H., et al. (2015) · BMC Cancer
Hepatocellular Carcinoma Treatment and PrognosisPI3K/AKT/mTOR signaling in cancer
Cited by 125
- Verified
Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer
Au, A., Lam, W., Tsang, J., Yau, T., Soong, I., Yeo, W., Suen, J., Ho, W. M., Wong, K., Kwong, A., et al. (2013) · Psycho-Oncology
Cancer survivorship and careWomen's cancer prevention and management
Cited by 95
- Verified
The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis
Lam, W. W. T., Tsang, J., Yeo, W., Suen, J., Ho, W. M., Yau, T. K., Soong, I., Wong, K. Y., Kwong, A., Suen, D., et al. (2014) · Supportive Care in Cancer
Cancer survivorship and careWomen's cancer prevention and management
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free